2026 Q2 Portfolio Activity
In 2026 Q2, Knott David M Jr maintained a portfolio of 96 distinct positions. The most significant new addition was Catalyst Pharmaceuticals, Inc., now representing 1.89% of the total fund value. They heavily accumulated shares in Cullinan Therapeutics, Inc., increasing the position by 185.9%. The fund also reduced its exposure to LPL Financial Holdings Inc. by 77.2%.
Position History
hover any row below to update
Loading…
Total Positions
96
Quarter
2026 Q2
Top Holding
GOOG (17.1%)
Top 10 Concentration
62.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 96
Knott David M Jr Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
GOOG
Alphabet Inc-Cl...
|
Communication Services | 17.07% | 15.61% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
91,420 | $32,301,429 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
APO
Apollo Global M...
|
Financial Services | 14.07% | 14.92% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
225,000 | $26,619,750 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
SNDX
Syndax Pharmace...
|
Healthcare | 5.05% | 5.87% |
#3
Prev: #3
|
3.5 |
—
|
15,245 | 3.6% |
P
S
|
437,245 | $9,558,176 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
XERS
Xeris Biopharma...
|
Healthcare | 4.44% | 3.66% |
#4
2
Prev: #6
|
3.3 |
—
|
no change | no change |
P
S
|
1,060,000 | $8,395,200 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
TVTX
Travere Therape...
|
Healthcare | 4.42% | 2.49% |
#5
7
Prev: #12
|
2.8 |
—
|
6,649 | 4.7% |
P
S
|
147,282 | $8,367,090 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
PTGX
Protagonist The...
|
Healthcare | 4.08% | 3.95% |
#6
1
Prev: #5
|
2.6 |
—
|
no change | no change |
P
S
|
63,000 | $7,722,540 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
BBIO
Bridgebio Pharm...
|
Healthcare | 3.66% | 3.98% |
#7
3
Prev: #4
|
2.0 |
—
|
2,850 | 3.2% |
P
S
|
92,850 | $6,915,468 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
IOVA
Iovance Biother...
|
Healthcare | 3.52% | 3.34% |
#8
Prev: #8
|
2.4 |
—
|
no change | no change |
P
S
|
1,600,000 | $6,656,000 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
ALKS
Alkermes PLC
|
Healthcare | 3.37% | 2.53% |
#9
2
Prev: #11
|
1.8 |
—
|
1,759 | 1.5% |
P
S
|
121,759 | $6,379,563 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
JPM
JPMorgan Chase ...
|
Financial Services | 3.13% | 3.41% |
#10
3
Prev: #7
|
1.8 |
—
|
-1,379 | -7.1% |
P
S
|
18,098 | $5,924,018 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
JAAA
Janus Henderson...
|
ETF | 2.50% | 2.80% |
#11
1
Prev: #10
|
2.0 |
—
|
no change | no change |
P
S
|
93,528 | $4,722,229 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
N/A
LPL Financial H...
|
|
Unknown | 2.46% | 2.95% |
#12
3
Prev: #9
|
2.0 |
—
|
no change | no change |
P
S
|
16,500 | $4,647,720 | — | 13F Filing | 2026-06-30 | 2026-08-12 | ||
|
COGT
Cogent Bioscien...
|
Healthcare | 2.27% | 2.38% |
#13
Prev: #13
|
2.9 |
—
|
7,081 | 6.8% |
P
S
|
111,081 | $4,298,835 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
TGTX
TG Therapeutics...
|
Healthcare | 1.94% | 1.78% |
#14
3
Prev: #17
|
0.8 |
—
|
-23,162 | -25.7% |
P
S
|
66,839 | $3,672,135 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
CLST
Catalyst Pharma...
|
Financial Services | 1.89% | — |
#15
Prev: #—
|
4.3 |
—
|
114,000 | — |
NEW
|
114,000 | $3,583,020 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
AGIO
Agios Pharmaceu...
|
Healthcare | 1.86% | 1.87% |
#16
1
Prev: #15
|
1.2 |
—
|
2,000 | 2.1% |
P
S
|
95,058 | $3,527,602 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
VRDN
Viridian Therap...
|
Healthcare | 1.76% | 2.11% |
#17
3
Prev: #14
|
1.7 |
—
|
no change | no change |
P
S
|
181,000 | $3,324,970 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
RLMD
Relmada Therape...
|
Healthcare | 1.65% | 1.82% |
#18
2
Prev: #16
|
1.2 |
—
|
11,700 | 2.7% |
P
S
|
451,000 | $3,120,920 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
RCUS
Arcus Bioscienc...
|
Healthcare | 1.32% | 1.04% |
#19
3
Prev: #22
|
1.5 |
—
|
no change | no change |
P
S
|
81,241 | $2,504,660 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
CYBN
Cybin Inc
|
Unknown | 1.29% | 1.00% |
#20
4
Prev: #24
|
2.5 |
—
|
20,000 | 5.7% |
P
S
|
370,000 | $2,445,700 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
XBI
SPDR S&P Biotec...
|
ETF | 1.25% | 1.14% |
#21
1
Prev: #20
|
1.5 |
—
|
no change | no change |
P
S
|
15,000 | $2,373,750 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
RZLT
Rezolute, Inc.
|
Healthcare | 1.02% | 0.67% |
#22
9
Prev: #31
|
1.4 |
—
|
no change | no change |
P
S
|
370,000 | $1,924,000 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
AB
AllianceBernste...
|
Financial Services | 0.89% | 1.07% |
#23
2
Prev: #21
|
1.4 |
—
|
no change | no change |
P
S
|
48,000 | $1,690,560 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
MDGL
Madrigal Pharma...
|
Healthcare | 0.85% | 0.62% |
#24
9
Prev: #33
|
3.3 |
—
|
1,000 | 50.0% |
P
S
|
3,000 | $1,610,850 | 2022 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
ATRC
AtriCure, Inc.
|
Healthcare | 0.76% | 0.87% |
#25
2
Prev: #27
|
1.3 |
—
|
no change | no change |
P
S
|
51,400 | $1,438,172 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
DCGO
DocGo, Inc.
|
Healthcare | 0.73% | 1.00% |
#26
3
Prev: #23
|
1.3 |
—
|
no change | no change |
P
S
|
2,670,850 | $1,378,426 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
ARDX
Ardelyx, Inc.
|
Healthcare | 0.71% | 0.74% |
#27
1
Prev: #28
|
2.8 |
—
|
56,168 | 27.1% |
P
S
|
263,168 | $1,342,157 | 2022 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
RARE
Ultragenyx Phar...
|
Healthcare | 0.67% | 0.41% |
#28
13
Prev: #41
|
2.3 |
—
|
5,000 | 15.1% |
P
S
|
38,069 | $1,271,124 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
CLOZ
The Panagram BB...
|
ETF | 0.67% | 0.73% |
#29
Prev: #29
|
1.3 |
—
|
no change | no change |
P
S
|
47,807 | $1,263,061 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
CGEM
Cullinan Therap...
|
Healthcare | 0.67% | 0.20% |
#30
21
Prev: #51
|
3.3 |
—
|
44,982 | 185.9% |
P
S
|
69,182 | $1,259,804 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
JNJ
Johnson & Johns...
|
Healthcare | 0.66% | 0.72% |
#31
1
Prev: #30
|
1.3 |
—
|
no change | no change |
P
S
|
4,922 | $1,250,041 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
VERA
Vera Therapeuti...
|
Healthcare | 0.59% | 0.62% |
#32
2
Prev: #34
|
1.2 |
—
|
no change | no change |
P
S
|
26,000 | $1,115,660 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
OBIO
Orchestra Biome...
|
Healthcare | 0.58% | 0.64% |
#33
1
Prev: #32
|
1.2 |
—
|
no change | no change |
P
S
|
253,651 | $1,094,504 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
SPRB
Spruce Bioscien...
|
Healthcare | 0.57% | — |
#34
Prev: #—
|
3.7 |
—
|
20,000 | — |
NEW
|
20,000 | $1,080,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
N/A
Connect Biophar...
|
|
Unknown | 0.56% | 0.60% |
#35
Prev: #35
|
2.2 |
—
|
57,027 | 14.7% |
P
S
|
444,862 | $1,058,772 | — | 13F Filing | 2026-06-30 | 2026-08-12 | ||
|
IBB
iShares Biotech...
|
ETF | 0.55% | 0.55% |
#36
Prev: #36
|
1.2 |
—
|
no change | no change |
P
S
|
5,500 | $1,046,045 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
BIIB
Biogen Inc.
|
Healthcare | 0.46% | 0.44% |
#37
3
Prev: #40
|
1.2 |
—
|
no change | no change |
P
S
|
4,000 | $864,240 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
PFE
Pfizer Inc.
|
Healthcare | 0.41% | 0.54% |
#38
1
Prev: #37
|
1.2 |
—
|
no change | no change |
P
S
|
32,337 | $778,675 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
AAPL
Apple Inc.
|
Technology | 0.38% | 0.38% |
#39
3
Prev: #42
|
1.2 |
—
|
no change | no change |
P
S
|
2,494 | $721,664 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
CNQ
Canadian Natura...
|
Energy | 0.35% | 0.49% |
#40
1
Prev: #39
|
1.1 |
—
|
no change | no change |
P
S
|
16,800 | $663,600 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
PTHS
Pelthos Therape...
|
Healthcare | 0.33% | 0.26% |
#41
7
Prev: #48
|
0.6 |
—
|
1,000 | 4.7% |
P
S
|
22,073 | $623,783 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
IBM
International B...
|
Technology | 0.32% | 0.31% |
#42
4
Prev: #46
|
1.1 |
—
|
no change | no change |
P
S
|
2,142 | $602,352 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
MSFT
Microsoft Corpo...
|
Technology | 0.32% | 0.35% |
#43
Prev: #43
|
1.1 |
—
|
no change | no change |
P
S
|
1,600 | $596,832 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
VSTM
Verastem Inc.
|
Healthcare | 0.31% | 0.33% |
#44
Prev: #44
|
2.6 |
—
|
51,000 | 49.0% |
P
S
|
155,000 | $592,100 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
KURA
Kura Oncology, ...
|
Healthcare | 0.31% | 0.26% |
#45
4
Prev: #49
|
1.1 |
—
|
no change | no change |
P
S
|
52,767 | $578,854 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
SLDB
Solid Bioscienc...
|
Healthcare | 0.30% | 0.20% |
#46
6
Prev: #52
|
2.1 |
—
|
9,065 | 19.2% |
P
S
|
56,208 | $561,518 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
N/A
DuPont de Nemou...
|
|
Unknown | 0.27% | — |
#47
Prev: #—
|
3.6 |
—
|
3,767 | — |
NEW
|
3,767 | $510,956 | — | 13F Filing | 2026-06-30 | 2026-08-12 | ||
|
INSM
Insmed Incorpor...
|
Healthcare | 0.24% | — |
#48
Prev: #—
|
3.6 |
—
|
4,253 | — |
NEW
|
4,253 | $453,455 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
LBRX
LB Pharmaceutic...
|
Healthcare | 0.22% | — |
#49
Prev: #—
|
3.6 |
—
|
12,965 | — |
NEW
|
12,965 | $420,779 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
CDNA
CareDx, Inc.
|
Healthcare | 0.21% | — |
#50
Prev: #—
|
3.6 |
—
|
13,630 | — |
NEW
|
13,630 | $388,455 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 |
Showing 1-50 of 96 holdings